NCT05881369View on ClinicalTrials.gov

Examining Clinical Research Participation for Substance Abuse Disorder Patient

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Substance Abuse Disorder
Trial Locations (1)

94107

Power Life Sciences, San Francisco

Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT05881369 - Examining Clinical Research Participation for Substance Abuse Disorder Patient | Biotech Hunter | Biotech Hunter